Fund Tracker
WOCKPHARMANSEHealthcarePharmaceuticals & Biotechnology

Wockhardt Limited

₹2,265.60NSE close, 25 Sep 2026
Data as of10 sources, each card shows its own date
MF: Aug 2026 portfolios (monthly), 20 AMCsShares outstanding and close: NSE, 25 Sep 2026Delivery: NSE bhavcopy, 25 Sep 2026 · 30 days collectedDeals: NSE deal files, 25 Sep 2026 · collected since 25 Sep 2026SLBM: NSE, 25 Sep 2026 · 30 days collectedMTF: NSE, 24 Sep 2026 · 29 days collectedFlags: NSE, 25 Sep 2026FPI: Shareholding pattern as of 30 Jun 2026, filed 7 Aug 2026Pledge: Shareholding pattern as of 30 Jun 2026Insider: Disclosures filed 29 Jun 2026 to 26 Sep 2026 (collected since 3 May 2026)
MF holding, % of equity
1.86%▼ −0.40 pp
Aug 2026 · change vs Jul 2026 over 20 AMCs with both months, all schemes
FPI holding, % of equity
7.22%
as of 30 Jun 2026
Fund houses holding
5▲ +1
1 entered, 0 exited · Aug 2026 · index funds hidden
Promoter pledge
14.68%
as of 30 Jun 2026

What changed

5 tracked fund houses held WOCKPHARMA in Aug 2026. UTI Mutual Fund entered.

All tracked schemes together held 30.28 lakh shares, 1.86% of equity, worth ₹570 cr at the end of Aug 2026.

Index and arbitrage funds held 0.46% of equity; they are left out of the fund-house counts.

MF houses

Aug 2026
5▲ +1 m/m
New1Added0Reduced4Exited0

Top buyer UTI Mutual Fund, +0.00% of equity. Top seller Mirae Asset Mutual Fund, −0.37% of equity. Index and arbitrage funds hidden.

AMC portfolios, Aug 2026 · 20 AMCs trackedSource: AMC monthly portfolios (SEBI disclosure) 5 fund houses →

Named FPIs at 1% or more

as of 30 Jun 2026
7.22%

FPI category I + II, % of total shares · 0 named at 1% or more

No FPI held 1% or more of WOCKPHARMA on 30 Jun 2026.

Shareholding pattern as of 30 Jun 2026, filed 7 Aug 2026Source: NSE shareholding pattern filings (XBRL), quarterly

Insider and promoter

29 Jun 2026 to 26 Sep 2026
No insider or promoter trade in WOCKPHARMA was disclosed 29 Jun 2026 to 26 Sep 2026.
Disclosures filed 29 Jun 2026 to 26 Sep 2026 (collected since 3 May 2026)Source: NSE insider trading disclosures (SEBI PIT, XBRL)

Bulk and block deals

25 Sep 2026
No bulk or block deals in WOCKPHARMA on 25 Sep 2026.
NSE deal files, 25 Sep 2026 · collected since 25 Sep 2026Source: NSE bulk.csv and block.csv, daily

Promoter pledge

as of 30 Jun 2026
14.68%

of promoter holding · 7.21% of total shares

Promoters had pledged 1.17 cr of their 7.98 cr shares on 30 Jun 2026; 1.17 cr encumbered in all (pledge, NDU and other).

Shareholding pattern as of 30 Jun 2026Source: NSE shareholding pattern filings (XBRL), quarterly

SLBM borrowing

25 Sep 2026
248 sh■ no change vs 24 Sep 2026

percentile 93 of 30 days collected

248 shares, under 0.01% of equity in SLBS open positions at the end of 25 Sep 2026; that day sits at percentile 93 of 30 days collected. No SLBM trades in WOCKPHARMA on 25 Sep 2026.

NSE, 25 Sep 2026 · 30 days collectedSource: NSE SLBS open positions (slb_openpos) and SLBM bhavcopy (SLBM_BC), daily

MTF book

24 Sep 2026
20.77 lakh sh▲ +39,850 vs 23 Sep 2026

percentile 41 of 29 days collected · ₹384 cr financed

20.77 lakh shares, 1.28% of equity in the margin trading book at the end of 24 Sep 2026; that day sits at percentile 41 of 29 days collected.

NSE, 24 Sep 2026 · 29 days collectedSource: NSE margin trading disclosure (mrg_trading), daily

Delivery

25 Sep 2026
35.5%▼ −0.7 pp vs 20-day average

20-day average 36.2% · percentile 40 of 30 days collected

35.5% of the shares traded on 25 Sep 2026 were delivered, against a 20-day average of 36.2%; that day sits at percentile 40 of 30 days collected.

NSE bhavcopy, 25 Sep 2026 · 30 days collectedSource: NSE security-wise delivery file (sec_bhavdata_full), daily

Red flags

25 Sep 2026
No F&O

WOCKPHARMA has no F&O contracts in NSE's combined open-interest file, so the F&O ban does not apply. NSE listed WOCKPHARMA under no ASM or GSM stage on 25 Sep 2026. Pledge invocations are not collected yet.

NSE, 25 Sep 2026Source: NSE F&O ban file, combined OI (MWPL), surveillance indicators (REG1_IND), daily